Quotes for Double Bond Pharmaceutical International AB
Right Now
- +/-
- %
- Latest
- High
- Low
- Volume
- Turnover ()
- Time (Latest trade)
Board
CEO
- Igor Lokot
Chairperson of the Board
- Sanna Rejnlander
Board
- Igor Lokot
- Irina Zaitseva
- Sergey Yanitsky
Double Bond Pharmaceutical, DBP, is a pharmaceutical company. The main focus is on the treatment of severe forms of cancer, infections and autoimmune diseases. The research is based on the company's proprietary technology. The products are sold under separate trademarks and collaboration on product development is done together with other players in the field. The company is based in Uppsala.
CEO
Chairperson of the Board
Board
Name | Capital % | Votes % | Date |
---|---|---|---|
Igor Lokot | 9,46 | 16,80 | 2024-03-26 |
Per Ahlström | 7,44 | 6,83 | 2024-03-26 |
KSDR Hamberg AB | 7,21 | 6,63 | 2024-03-26 |
QQM Fund Management AB | 6,11 | 5,62 | 2024-03-26 |
Carl Carvalho | 4,26 | 3,92 | 2024-03-26 |
Investentia AB | 3,90 | 3,58 | 2024-03-26 |
Lars-Åke Börje Flarke | 3,65 | 3,36 | 2024-03-26 |
Avanza Pension | 2,84 | 2,61 | 2024-03-26 |
Magnus Hamberg | 2,40 | 2,21 | 2024-03-26 |
Obain AB | 1,40 | 1,29 | 2024-03-26 |
2024-05-24 Delårsrapport 2024-Q1
2024-08-27 Delårsrapport 2024-Q2